Hereditary Neuropathies: Update 2017

Abstract

Hereditary neuropathy is an umbrella term for a group of nonsyndromic conditions with a prevalence of approximately 1:2,500. In addition to the most frequent form, Charcot–Marie–Tooth's disease (CMT, or hereditary motor and sensory neuropathy), there are additional entities such as hereditary neuropathy with liability to pressure palsies (HNPP), hereditary motor neuropathies (HMNs), and hereditary sensory and autonomic neuropathies (HSANs). With the exception of HNPP, which is almost always caused by defects of the PMP22 gene, all other forms show genetic heterogeneity with altogether close to 100 genes involved. Mutation detection rates vary considerably, reaching up to 80% in demyelinating CMT (CMT1) but are still as low as 10 to 30% in axonal CMT (CMT2), HMN, and HSAN. Based on current information, analysis of only four genes (PMP22, GJB1, MPZ, MFN2) identifies 80 to 90% of CMT-causing mutations that can be detected in all known disease genes. For the remaining patients, parallel analysis of multiple neuropathy genes using next-generation sequencing is now replacing phenotype-oriented multistep gene-by-gene sequencing. Such approaches tend to generate a wealth of genetic information that requires comprehensive evaluation of the pathogenic relevance of identified variants. In this review, we present current classification systems, specific phenotypic clues, and genetic testing algorithms in the different subgroups of hereditary neuropathies.

Keywords

Charcot–Marie–Tooth's disease - hereditary motor and sensory neuropathy - hereditary neuropathy with liability to pressure palsies - hereditary motor neuropathy - distal spinal muscular atrophy - hereditary sensory and autonomic neuropathy - genetic testing algorithm - genotype–phenotype correlation

• References

• 1 Barreto LC, Oliveira FS, Nunes PS. , et al. Epidemiologic study of Charcot-Marie-Tooth disease: a systematic review. Neuroepidemiology 2016; 46 (03) 157-165
• 2 Rudnik-Schöneborn S, Tölle D, Senderek J. , et al. Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients. Clin Genet 2016; 89 (01) 34-43
• 3 De Jonghe P, Timmerman V, Van Broeckhoven C. 2nd Workshop of the European CMT Consortium: 53rd ENMC International Workshop on Classification and Diagnostic Guidelines for Charcot-Marie-Tooth Type 2 (CMT2-HMSN II) and Distal Hereditary Motor Neuropathy (distal HMN-Spinal CMT) 26-28 September 1997, Naarden, The Netherlands. Neuromuscul Disord 1998; 8 (06) 426-431
• 4 Weis J, Claeys KG, Roos A. , et al. Towards a functional pathology of hereditary neuropathies. Acta Neuropathol 2017; 133 (04) 493-515
• 5 Korinthenberg R, Rudnik-Schöneborn S, Müller-Felber W. Differentialdiagnose der hereditären Neuropathien im Kindes- und Jugendalter. AWMF Leitlinien. Konsensfindung in der Neuropädiatrie 2016; Q9: 1-20
• 6 Weis J, Senderek J. Introduction to the hereditary neuropathies. In: Vallat JM, Weis J. , eds. Peripheral Nerve Disorders. Pathology and Genetics. New York, NY: Wiley; 2014: 59-61
• 7 England JD, Gronseth GS, Franklin G. , et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72 (02) 185-192
• 8 Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011; 69 (01) 22-33
• 9 Murphy SM, Laura M, Fawcett K. , et al. Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 2012; 83 (07) 706-710
• 10 Gess B, Schirmacher A, Boentert M, Young P. Charcot-Marie-Tooth disease: frequency of genetic subtypes in a German neuromuscular center population. Neuromuscul Disord 2013; 23 (08) 647-651
• 11 Sivera R, Sevilla T, Vílchez JJ. , et al. Charcot-Marie-Tooth disease: genetic and clinical spectrum in a Spanish clinical series. Neurology 2013; 81 (18) 1617-1625
• 12 Fridman V, Bundy B, Reilly MM. , et al. Inherited Neuropathies Consortium. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry 2015; 86 (08) 873-878
• 13 DiVincenzo C, Elzinga CD, Medeiros AC. , et al. The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathy. Mol Genet Genomic Med 2014; 2 (06) 522-529
• 14 Zimoń M, Battaloğlu E, Parman Y. , et al. Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach. Neurogenetics 2015; 16 (01) 33-42
• 15 Lupski JR, Chance PF. Hereditary motor and sensory neuropathies involving altered dosage or mutation of PMP22: The CMT1A duplication and HNPP deletion. In: Dyck PJ, Thomas PK. , eds. Peripheral Neuropathy. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005: 1659-1680
• 16 Hattori N, Yamamoto M, Yoshihara T. , et al; Study Group for Hereditary Neuropathy in Japan. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain 2003; 126 (Pt 1): 134-151
• 17 Baets J, Deconinck T, De Vriendt E. , et al. Genetic spectrum of hereditary neuropathies with onset in the first year of life. Brain 2011; 134 (Pt 9): 2664-2676
• 18 Bird TD. Charcot-Marie-Tooth Neuropathy Type 1. 1998 Aug 31 [Updated 2015 Mar 26]. In: Pagon RA, Adam MP, Ardinger HH. , et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington; 1993– 2017. . Available at https://www.ncbi.nlm.nih.gov/books/NBK1205/
• 19 Russo M, Laurá M, Polke JM. , et al. Variable phenotypes are associated with PMP22 missense mutations. Neuromuscul Disord 2011; 21 (02) 106-114
• 20 Taioli F, Cabrini I, Cavallaro T, Acler M, Fabrizi GM. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene. Brain 2011; 134 (Pt 2): 608-617
• 21 Bird TD. Charcot-Marie-Tooth Neuropathy X Type 1. 1998 Jun 18 [Updated 2016 Sep 1]. In: Pagon RA, Adam MP, Ardinger HH. , et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington; 1993– 2017. . Available at https://www.ncbi.nlm.nih.gov/books/NBK1374/
• 22 Shy ME, Jáni A, Krajewski K. , et al. Phenotypic clustering in MPZ mutations. Brain 2004; 127 (Pt 2): 371-384
• 23 Sanmaneechai O, Feely S, Scherer SS. , et al; Inherited Neuropathies Consortium - Rare Disease Clinical Research Consortium (INC-RDCRC). Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene. Brain 2015; 138 (Pt 11): 3180-3192
• 24 Züchner S, Mersiyanova IV, Muglia M. , et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36 (05) 449-451
• 25 Verhoeven K, Claeys KG, Züchner S. , et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 2006; 129 (Pt 8): 2093-2102
• 26 Bombelli F, Stojkovic T, Dubourg O. , et al. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features. JAMA Neurol 2014; 71 (08) 1036-1042
• 27 Choi BO, Nakhro K, Park HJ. , et al. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients. Clin Genet 2015; 87 (06) 594-598
• 28 Mouton P, Tardieu S, Gouider R. , et al. Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology 1999; 52 (07) 1440-1446
• 29 Koike H, Hirayama M, Yamamoto M. , et al. Age associated axonal features in HNPP with 17p11.2 deletion in Japan. J Neurol Neurosurg Psychiatry 2005; 76 (08) 1109-1114
• 30 Harding AE. Inherited neuronal atrophy and degeneration predominantly of lower motor neurons. In: Dyck PJ, Thomas PK, Griffin JW. , et al., eds. Peripheral Neuropathy. Philadelphia, PA: WB Saunders; 1993: 1051-1064
• 31 Kennerson ML, Nicholson GA, Kaler SG. , et al. Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am J Hum Genet 2010; 86 (03) 343-352
• 32 Dierick I, Baets J, Irobi J. , et al. Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study. Brain 2008; 131 (Pt 5): 1217-1227
• 33 Rossor AM, Kalmar B, Greensmith L, Reilly MM. The distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry 2012; 83 (01) 6-14
• 34 Bansagi B, Griffin H, Whittaker RG. , et al. Genetic heterogeneity of motor neuropathies. Neurology 2017; 88 (13) 1226-1234
• 35 Rotthier A, Baets J, De Vriendt E. , et al. Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain 2009; 132 (Pt 10): 2699-2711
• 36 Davidson G, Murphy S, Polke J. , et al. Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort. J Neurol 2012; 259 (08) 1673-1685
• 37 Jani-Acsadi A, Krajewski K, Shy ME. Charcot-Marie-Tooth neuropathies: diagnosis and management. Semin Neurol 2008; 28 (02) 185-194
• 38 Schenone A, Nobbio L, Monti Bragadin M, Ursino G, Grandis M. Inherited neuropathies. Curr Treat Options Neurol 2011; 13 (02) 160-179
• 39 Burns TM, Ryan MM, Darras B, Jones Jr HR. Current therapeutic strategies for patients with polyneuropathies secondary to inherited metabolic disorders. Mayo Clin Proc 2003; 78 (07) 858-868
• 40 Planté-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol 2011; 10 (12) 1086-1097